A Randomized, Double-Blinded Phase II Study of Maintenance Pembrolizumab versus Placebo after Firstline Chemotherapy in Patients with Metastatic Urothelial Cancer
|Effective start/end date||6/1/16 → 5/31/21|
- HOOSIER CANCER RESEARCH NETWORK, INC
- MERCK AND CO INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.